Prescription Medicines Schedule




NEW ZEALAND GAZETTE, No. 77 — 3 AUGUST 2017

Ixekizumab

Ketoprofen; except when specified elsewhere in this notice

Lenvatinib

Lesinurad

Levomilnacipran

Levonorgestrel; except when specified elsewhere in this notice; except in medicines for use as emergency postcoital contraception when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health; except when supplied for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme

Lignocaine; for injection except when used as a local anaesthetic in practice by a nurse whose scope of practice permits the performance of general nursing functions or by a podiatrist registered with the Podiatry Board or by a dental therapist or oral health therapist registered with the Dental Council; for ophthalmic use except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; for oral use except in throat lozenges in medicines containing 30 milligrams or less per dose form; for external use in medicines containing more than 10%; except in throat sprays in medicines containing 2% or less; except when specified elsewhere in this notice

Lipegfilgrastim

Lisdexamfetamine

Loratadine; except when specified elsewhere in this schedule; except in divided solid dosage forms for oral use containing 10 milligrams or less per dose form for the treatment of seasonal allergic rhinitis when sold in the manufacturer’s original pack containing not more than 10 days’ supply

Lumacaftor

Mepolizumab

Methylhexanamine (1,3-dimethylamylamine (DMAA)); except when present as an unmodified, naturally occurring substance

Milnacipran

Molracetam

Naloxegol

Naloxone; except when provided as part of an approved emergency kit for the treatment of opioid overdose

Nebracetam (and its stereoisomers)

Nefiracetam

Nepidermin

Netupitant

Nicoracetam

Nitazoxanide

Nivolumab

Noopept (and its stereoisomers)

Norethisterone; except when supplied for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme

Ocrelizumab

Olaparib

Osimertinib

Otilonium bromide

Oxiracetam (and its stereoisomers)

Palbociclib

46



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2017, No 77





✨ LLM interpretation of page content

🏥 Schedule 1 - Prescription Medicines (continued from previous page)

🏥 Health & Social Welfare
Prescription Medicines, Schedule, Ixekizumab, Ketoprofen, Lenvatinib, Lesinurad, Levomilnacipran, Levonorgestrel, Lignocaine, Lipegfilgrastim, Lisdexamfetamine, Loratadine, Lumacaftor, Mepolizumab, Methylhexanamine, Milnacipran, Molracetam, Naloxegol, Naloxone, Nebracetam, Nefiracetam, Nepidermin, Netupitant, Nicoracetam, Nitazoxanide, Nivolumab, Noopept, Norethisterone, Ocrelizumab, Olaparib, Osimertinib, Otilonium bromide, Oxiracetam, Palbociclib